Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lövgren, Karin M.
~ 200  Ergebnisse:
Personensuche X
?
1

FVIII activity following FVIII protein infusion or FVIII ge..:

Lövgren, Karin M. ; Larsen, Malte S. ; Zintner, Shannon M....
Journal of Thrombosis and Haemostasis.  18 (2020)  7 - p. 1586-1597 , 2020
Link: https://doi.org/10.1111/..
 
?
2

FVIII activity following FVIII protein infusion or FVIII ge..:

Lövgren, Karin M ; Larsen, Malte S ; Zintner, Shannon M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786582/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
3

A randomized first-in-human phase I trial of differentially..:

Tiono, Alfred B. ; Plieskatt, Jordan L. ; Ouedraogo, Alphonse...
Journal of Clinical Investigation.  134 (2024)  7 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
4

Vaccination with recombinant Parasite Surface Antigen 2 fro..:

Sjölander, Anders ; Baldwin, Tracey M ; Curtis, Joan M..
Vaccine.  16 (1998)  20 - p. 2077-2084 , 1998
Link: https://doi.org/10.1016/..
 
?
5

Preclinical development of a Pfs230-Pfs48/45 chimeric malar..:

Singh, Susheel K. ; Plieskatt, Jordan ; Chourasia, Bishwanath K....
npj Vaccines.  6 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
6

A Reproducible and Scalable Process for Manufacturing a Pfs..:

Singh, Susheel K. ; Plieskatt, Jordan ; Chourasia, Bishwanath K....
Frontiers in Immunology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
7

Matrix-M™ adjuvanted envelope protein vaccine protects agai..:

Magnusson, Sofia E. ; Karlsson, Karin H. ; Reimer, Jenny M....
Vaccine.  32 (2014)  7 - p. 800-808 , 2014
Link: https://doi.org/10.1016/..
 
?
8

Immune enhancing properties of the novel Matrix-M™ adjuvant..:

Magnusson, Sofia E. ; Reimer, Jenny M. ; Karlsson, Karin H....
Vaccine.  31 (2013)  13 - p. 1725-1733 , 2013
Link: https://doi.org/10.1016/..
 
?
9

Matrix-M™ Adjuvant Induces Local Recruitment, Activation an..:

Reimer, Jenny M. ; Karlsson, Karin H. ; Lövgren-Bengtsson, Karin...
PLoS ONE.  7 (2012)  7 - p. e41451 , 2012
Link: https://doi.org/10.1371/..
 
?
10

Low titer maternal antibodies can both enhance and suppress..:

Nguyen, Trang V. ; Yuan, Lijuan ; P. Azevedo, Marli S....
Vaccine.  24 (2006)  13 - p. 2302-2316 , 2006
Link: https://doi.org/10.1016/..
 
?
11

A recombinant prime, peptide boost vaccination strategy can..:

Davis, David ; Morein, Bror ; Åkerblom, Lennart...
Vaccine.  15 (1997)  15 - p. 1661-1669 , 1997
Link: https://doi.org/10.1016/..
 
?
12

DataSheet_1_A Reproducible and Scalable Process for Manufac..:

Susheel K. Singh ; Jordan Plieskatt ; Bishwanath K. Chourasia...
doi:10.3389/fimmu.2020.606266.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
13

Preclinical development of a Pfs230-Pfs48/45 chimeric malar..:

Singh, Susheel K ; Plieskatt, Jordan ; Chourasia, Bishwanath K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511065/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Preclinical development of a Pfs230-Pfs48/45 chimeric malar..:

Susheel K. Singh ; Jordan Plieskatt ; Bishwanath K. Chourasia...
https://doi.org/10.1038/s41541-021-00383-8.  , 2021
Link: https://doi.org/10.1038/..
 
?
15

A Reproducible and Scalable Process for Manufacturing a Pfs..:

Singh, Susheel K ; Plieskatt, Jordan ; Chourasia, Bishwanath K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832176/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15